- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03586141
Pronto for Patient Blood Management
February 17, 2019 updated by: Dr. Eva Wittenmeier, Johannes Gutenberg University Mainz
Validation of Hb-measurement of Pronto ® as Screening Tool for Preoperative Diagnostic of Anemia
The concept of Patient Blood Management requires preoperative diagnostic of anemia.
To avoid the harmful procedure of venous puncture for drawing a blood sample, noninvasive measurement of hemoglobin has been developed.
However noninvasive measurement of hemoglobin has yet been not accurate enough to replace invasive hemoglobin measurement.
This study investigates if a noninvasive measurement tool can serve as a screening tool to find out for which patients invasive measurement of hemoglobin is necessary.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The noninvasive hemoglobin measurement tool Pronto® can measure hemoglobin noninvasively by a sensor clip.
The investigators analyzed previous studies with the Pronto device and calculated two cut-off values of the noninvasive hemoglobin device.
If noninvasive hemoglobin values are higher than cut off value 1 the investigators postulate that with a sensitivity of 99% the participant has no anemia.
To confirm this, participants who are supposed to undergo elective surgery and come to the preoperative anesthetic ambulance are measured by the Pronto-device.
The noninvasive measurements are compared with the laboratory values of the patients and cut-off value 1 can be confirmed.
Study Type
Interventional
Enrollment (Actual)
1129
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mainz, Germany, 55131
- Johannes Gutenbert University Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults and children >=3kg that are planned to undergo elective surgery
- Written informed consent
Exclusion Criteria:
- no written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: noninvasive measurement of hemoglobin
All participating patients are measured by the Pronto® hemoglobin measurement tool
|
All patients who are planned to undergo elective surgery come to the preoperative anesthetic ambulance.
They are all measured by the Pronto® hemoglobin measurement tool
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validation of a postulated noninvasively measured haemoglobin value as a cut-off value for the decision wether invasively measuring of haemoglobin concentration for preoperative patient blood management is necessary.
Time Frame: five to ten minutes
|
Previous studies show that noninvasively measured haemoglobin is not accurate enough to determine exactly the haemoglobin value for preoperative diagnosis of anaemia.
We postulate that noninvasive haemoglobin measurement can be used as a screening tool to decide wether invasive measurement of haemoglobin is necessary.
We calculated a cut-off value 1 by analysing previous studies.
Noninvasive haemoglobin measurements that are above the cut-off-value are postulated to show that the patient is not anaemic with a sensitivity of 99%.
|
five to ten minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validation of postulated non invasively measured haemoglobin value as a cut off-value 2
Time Frame: five to ten minutes
|
We calculated a cut-off value 2 by analysing previous studies.
Noninvasive haemoglobin measurements that are below the cut-off-value 2 are postulated to show that the patient is anaemic with a speciality of 99%.
|
five to ten minutes
|
Agreement between invasive and noninvasive measurement in adults and children
Time Frame: five to ten minutes
|
Noninvasive haemoglobin measurement values are compared with invasive haemoglobin measurement values
|
five to ten minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Eva Wittenmeier, MD, Johannes Gutenberg University Centre, department of anaesthesiology, Langenbeckstraße 1, 55131 Mainz, Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 22, 2018
Primary Completion (Actual)
November 30, 2018
Study Completion (Actual)
November 30, 2018
Study Registration Dates
First Submitted
June 21, 2018
First Submitted That Met QC Criteria
July 12, 2018
First Posted (Actual)
July 13, 2018
Study Record Updates
Last Update Posted (Actual)
February 19, 2019
Last Update Submitted That Met QC Criteria
February 17, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pronto for PBM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Cornell UniversityUniversity of California, Los AngelesCompletedPregnancy Anemia | Newborn; AnemiaUnited States
-
Peking Union Medical College HospitalRecruiting
Clinical Trials on Pronto® hemoglobin measurement tool
-
University Children's Hospital, ZurichQueen Margaret UniversityCompletedCerebral Palsy | Child Development | Proprioceptive Disorders | Upper Motor Neurone LesionSwitzerland
-
Reflexion Health, Inc.United States Naval Medical Center, San DiegoCompleted
-
University of EdinburghNHS LothianRecruiting
-
Northwestern UniversityCompletedPostpartum Hemorrhage | Postsurgical Bleeding | Abdominal Ultrasound | FAST Scan | Non-invasive Hemoglobin MeasurementUnited States
-
University of AarhusCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingDenmark
-
University Hospital, Clermont-FerrandTerminatedVisual Deficiency | Congenital Blindness | Acquired BlindnessFrance
-
University of Colorado, DenverNational Cancer Institute (NCI)RecruitingPediatric Cancer | SurvivorshipUnited States
-
Ataturk Training and Research HospitalUnknown
-
Klinik Hirslanden, ZurichUnknownTranscutaneous Continuous Hemoglobin Measurement
-
Duke UniversityCompletedOverweight, Obesity, Small for Gestational Age, PrematurityUnited States